Evidence map›Paper›PMID 33768132›Full record

ArticleMolecular therapy. Methods & clinical development2021

Alginate hydrogel polymers enable efficient delivery of a vascular-targeted AAV vector into aortic tissue.

Anca Remes, Dima Ibrahim Basha, Thomas Puehler, Christopher Borowski, Susanne Hille, Laura Kummer, Andreas H Wagner, Markus Hecker, Jasmin Soethoff, Georg Lutter and 5 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Methods & clinical development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Anca RemesDepartment of Internal Medicine III, University of Kiel, Kiel, Germany.
Dima Ibrahim BashaDepartment of Internal Medicine III, University of Kiel, Kiel, Germany.
Thomas PuehlerGerman Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Germany.
Christopher BorowskiDepartment of Internal Medicine III, University of Kiel, Kiel, Germany.
Susanne HilleDepartment of Internal Medicine III, University of Kiel, Kiel, Germany.
Laura KummerDepartment of Anesthesiology, University Hospital Heidelberg, Heidelberg, Germany.
Andreas H WagnerDepartment of Cardiovascular Physiology, Heidelberg University, Heidelberg, Germany.
Markus HeckerDepartment of Cardiovascular Physiology, Heidelberg University, Heidelberg, Germany.
Jasmin SoethoffDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Georg LutterGerman Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Germany.
Derk FrankDepartment of Internal Medicine III, University of Kiel, Kiel, Germany.
Rawa ArifDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Norbert FreyDepartment of Internal Medicine III, University of Kiel, Kiel, Germany.
Marcin ZaradzkiDepartment of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Oliver J MüllerDepartment of Internal Medicine III, University of Kiel, Kiel, Germany.
Christian-Albrechts-Universität zu Kiel · DEGerman Centre for Cardiovascular Research · DEUniversity Hospital Heidelberg · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene therapeutic approaches to aortic diseases require efficient vectors and delivery systems for transduction of endothelial cells (ECs) and smooth muscle cells (SMCs). Here, we developed a novel strategy to efficiently deliver a previously described vascular-specific adeno-associated viral (AAV) vector to the abdominal aorta by application of alginate hydrogels. To efficiently transduce ECs and SMCs, we used AAV9 vectors with a modified capsid (AAV9SLR) encoding enhanced green fluorescent protein (EGFP), as wild-type AAV vectors do not transduce ECs and SMCs well. AAV9SLR vectors were embedded into a solution containing sodium alginate and polymerized into hydrogels. Gels were surgically implanted around the adventitia of the infrarenal abdominal aorta of adult mice. Three weeks after surgery, an almost complete transduction of both the endothelium and tunica media adjacent to the gel was demonstrated in tissue sections. Hydrogel-mediated delivery resulted in induction of neutralizing antibodies but did not cause inflammatory responses in serum or the aortic wall. To further determine the translational potential, aortic tissue from patients was embedded

Indexed as

AAV vectoradeno-associated virusalginate hydrogelaortaendothelial cellsgene therapysmooth muscle cellsvascular diseasevascular gene transfervascular system

Identifiers

PMID33768132
PMCPMC7973147
OpenAlexW3131091394

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.